Insiders · BCLI

BCLI insider transactions

Brainstorm Cell Therapeutics Inc. (BCLI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for BCLI

• 4d
  SEC Form 3 filed by new insider Pitts Peter Joe

  3 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 9d
  President & CEO Lebovits Chaim was granted 1,800,000 shares, increasing direct ownership by 896% to 2,000,960 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 9d
  EVP & Chief Business Officer Yablonka Uri was granted 150,000 shares, increasing direct ownership by 219% to 218,464 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 9d
  Officer Patlis Alla was granted 100,000 shares, increasing direct ownership by 225% to 144,349 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 9d
  Director Frenkel Jacob A was granted 200,000 shares, increasing direct ownership by 457% to 243,777 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 9d
  Director Arbel Irit was granted 120,000 shares, increasing direct ownership by 292% to 161,054 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Bairu Menghisteab

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Polverino Anthony J.

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Hartounian Hartoun

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Lindborg Stacy

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Naor Nir

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 18d
  SEC Form 4 filed by Director Dagher Ibrahim B.

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 516d
  Chief Medical Officer Dagher Ibrahim B. was granted 50,000 shares, increasing direct ownership by 297% to 66,849 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 516d
  Amendment: New insider Dagher Ibrahim B. claimed ownership of 505,742 shares (SEC Form 3)

  3/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  President & CEO Lebovits Chaim was granted 120,000 shares, increasing direct ownership by 148% to 200,960 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Frenkel Jacob A was granted 40,000 shares, increasing direct ownership by 1,059% to 43,777 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Polverino Anthony J. was granted 24,000 shares, increasing direct ownership by 1,387% to 25,730 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  EVP & Chief Business Officer Yablonka Uri was granted 60,000 shares, increasing direct ownership by 709% to 68,464 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Officer Patlis Alla was granted 40,000 shares, increasing direct ownership by 920% to 44,349 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Naor Nir was granted 30,666 shares, increasing direct ownership by 3,838% to 31,465 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Lindborg Stacy was granted 20,000 shares, increasing direct ownership by 71% to 48,229 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  EVP, Chief Operating Officer Hartounian Hartoun was granted 50,000 shares, increasing direct ownership by 2,500% to 52,000 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Bairu Menghisteab was granted 24,000 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 520d
  Director Arbel Irit was granted 30,666 shares, increasing direct ownership by 295% to 41,054 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 614d
  President & CEO Lebovits Chaim bought $11,308 worth of shares (23,836 units at $0.47), decreasing direct ownership by 93% to 80,960 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $7,774 worth of shares (15,000 units at $0.52), increasing direct ownership by 1% to 1,164,865 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $30,475 worth of shares (50,000 units at $0.61), increasing direct ownership by 5% to 1,149,865 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $18,865 worth of shares (40,000 units at $0.47), increasing direct ownership by 4% to 1,099,865 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $24,816 worth of shares (66,300 units at $0.37), increasing direct ownership by 7% to 1,059,865 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $50,666 worth of shares (135,000 units at $0.38), increasing direct ownership by 16% to 993,565 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $7,798 worth of shares (15,000 units at $0.52), increasing direct ownership by 2% to 858,565 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 676d
  Amendment: President & CEO Lebovits Chaim bought $131,411 worth of shares (245,072 units at $0.54), increasing direct ownership by 41% to 843,565 units (SEC Form 4)

  4/A - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 683d
  Chief Medical Officer Dagher Ibrahim B. sold $22,069 worth of shares (63,000 units at $0.35), closing all direct ownership in the company (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 712d
  EVP, Chief Operating Officer Hartounian Hartoun was granted 30,000 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 712d
  SEC Form 3 filed by new insider Hartounian Hartoun

  3 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 735d
  Lebovits Chaim was granted 15,000 shares, increasing direct ownership by 1% to 1,164,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 746d
  Lebovits Chaim was granted 50,000 shares, increasing direct ownership by 5% to 1,149,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 755d
  Lebovits Chaim was granted 40,000 shares, increasing direct ownership by 4% to 1,099,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 761d
  Lebovits Chaim was granted 66,300 shares, increasing direct ownership by 7% to 1,059,865 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 762d
  Lebovits Chaim was granted 135,000 shares, increasing direct ownership by 16% to 993,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 773d
  Lebovits Chaim was granted 15,000 shares, increasing direct ownership by 2% to 858,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 776d
  New insider Dagher Ibrahim B. claimed ownership of 253,000 shares (SEC Form 3)

  3 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 780d
  Lebovits Chaim was granted 245,072 shares, increasing direct ownership by 41% to 843,565 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 816d
  Lindborg Stacy was granted 241,935 shares, increasing direct ownership by 133% to 423,435 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 816d
  Yablonka Uri was granted 109,426 shares, increasing direct ownership by 624% to 126,969 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 816d
  Patlis Alla was granted 65,246 shares (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 816d
  Lebovits Chaim was granted 305,198 shares, increasing direct ownership by 104% to 598,493 units (SEC Form 4)

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1006d
  SEC Form 4: Lindborg Stacy bought $20,402 worth of shares (11,500 units at $1.77), increasing direct ownership by 7% to 181,500 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1036d
  SEC Form 4: Lindborg Stacy was granted 35,000 shares, increasing direct ownership by 26% to 170,000 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1038d
  SEC Form 4: Lebovits Chaim was granted 31,185 shares, increasing direct ownership by 12% to 293,295 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1082d
  SEC Form 4 filed by Naor Nir

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1082d
  SEC Form 3 filed by new insider Naor Nir

  3 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1133d
  SEC Form 4 filed by Taylor Kirk

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1133d
  SEC Form 3 filed by new insider Taylor Kirk

  3 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1141d
  SEC Form 4 filed by Lebovits Chaim

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1141d
  SEC Form 4 filed by Lindborg Stacy

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1251d
  SEC Form 4: Lindborg Stacy was granted 35,000 shares, increasing direct ownership by 140% to 60,000 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1251d
  SEC Form 4: Lebovits Chaim was granted 31,185 shares, increasing direct ownership by 20% to 187,110 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1521d
  SEC Form 4 filed by Frenkel Jacob A

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)
• 1546d
  SEC Form 4: Kern Ralph Dr. was granted 35,885 shares, increasing direct ownership by 19% to 223,310 units

  4 - BRAINSTORM CELL THERAPEUTICS INC. (0001137883) (Issuer)